Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: a retrospective study.
Lin KH, Chen SP, Fuh JL, Wang YF, Wang SJ. Efficacy, safety, and predictors of response to botulinum toxin type A in refractory chronic migraine: a retrospective study. J Chin Med Assoc. 2014 Jan; 77(1):10-5.